CSL Annual Report 2023

Note 18: Detailed Information – People Costs continued 26 Expected volatility is based on historical volatility (based on the remaining life assumption of each equity instrument, adjusted for expected changes). 27 PSUs are subject to an EPS growth and ROIC performance measure. 28 F air value of GESP shares is estimated based on the assumptions prevailing on the grant date. In accordance with the terms and conditions of the GESP plan, shares are issued at a 15% discount to the lower of the ASX market price on the first and last dates of the contribution period. Valuation assumptions and fair values of equity instruments granted The model inputs for share-based payments granted during the year ended 30 June 2023 included: Fair Value (A$) Share Price (A$) Exercise Price (A$) Expected Volatility26 Life Assumption Expected Dividend Yield Risk-free Interest Rates Performance Share Units (by grant date)27 1 September 2022 – Tranche 1 $286.27 $293.38 – 25.00% 24 months 1.23% 3.01% 1 November 2022 – Tranche 1 $267.12 $276.69 – 25.00% 34 months 1.25% 3.26% 1 March 2023 – Tranche 1 $285.54 $297.10 – 22.50% 30 months 1.60% 3.51% Restricted Share Units (by grant date) 1 September 2022 – Tranche 1 $291.59 $293.38 – 25.00% 6 months 1.23% 2.99% 1 September 2022 – Tranche 2 $289.80 $293.38 – 25.00% 12 months 1.23% 2.99% 1 September 2022 – Tranche 3 $288.91 $293.38 – 25.00% 15 months 1.23% 2.99% 1 September 2022 – Tranche 4 $288.03 $293.38 – 25.00% 18 months 1.23% 3.01% 1 September 2022 – Tranche 5 $286.27 $293.38 – 25.00% 24 months 1.23% 3.01% 1 September 2022 – Tranche 6 $284.52 $293.38 – 25.00% 30 months 1.23% 3.23% 1 September 2022 – Tranche 7 $282.78 $293.38 – 25.00% 36 months 1.23% 3.23% 1 March 2023 – Tranche 1 $294.90 $297.10 – 22.50% 6 months 1.50% 3.71% 1 March 2023 – Tranche 2 $292.71 $297.10 – 22.50% 12 months 1.50% 3.71% 1 March 2023 – Tranche 3 $290.11 $297.10 – 22.50% 18 months 1.60% 3.51% 1 March 2023 – Tranche 4 $287.82 $297.10 – 22.50% 24 months 1.60% 3.51% 1 March 2023 – Tranche 5 $285.54 $297.10 – 22.50% 30 months 1.60% 3.51% Rights (by grant date) 25 August 2022 – Tranche 1 $292.74 $294.46 – 25.00% 6 months 1.21% 2.94% 25 August 2022 – Tranche 2 $290.97 $294.46 – 25.00% 12 months 1.21% 2.94% GESP (by grant date)28 2 September 2022 – Tranche 1 $72.13 $295.99 $223.86 25.00% 6 months 1.23% 2.99% 3 March 2023 – Tranche 1 $43.26 $293.02 $249.76 22.50% 6 months 1.50% 3.71% Note 19: Detailed Information – Shareholder Returns Consolidated Entity 2023 US$m 2022 US$m Retained earnings Opening balance 13,504 12,253 Net profit for the year 2,194 2,255 Dividends paid to CSL Limited shareholders (1,085) (1,039) Transfer of gain on disposal of equity investments at fair value through OCI to retained earnings 7 – Actuarial gain on defined benefit plans 2 40 Deferred tax expense on actuarial gain/loss on defined benefit plans (1) (5) Closing balance 14,621 13,504 CSL Limited Annual Report 2022/23 155

RkJQdWJsaXNoZXIy MjE2NDg3